Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma
Authors
Jason Butler (ORCID: https://orcid.org/0000-0002-6422-4404)
Francesco d’Amore
Richard Tsang (ORCID: https://orcid.org/0000-0002-7487-8487)
Benhur Amanuel
Maher K. Gandhi
Daniel Roos
David P. LeBrun (ORCID: https://orcid.org/0000-0002-8695-0247)
Soi Cheng Law
Maja Ludvigsen (ORCID: https://orcid.org/0000-0001-5089-3271)
Richard Fisher (ORCID: https://orcid.org/0000-0001-9491-3764)
Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma
Jason Butler, Francesco d’Amore, Richard Tsang, Benhur Amanuel et al.
Citations
1 citations
Journal
EBioMedicine
Topics
Lymphoma Diagnosis and Treatment
Field-Weighted Citation Impact (FWCI)
0.42
article
Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma
Jason Butler, Francesco d’Amore, Richard Tsang, Benhur Amanuel, Maher K. Gandhi, Daniel Roos, David P. LeBrun, Soi Cheng Law, Maja Ludvigsen, Richard Fisher, Claire Melissa Vajdic, Karthik Nath, Muhammed B. Sabdia, Tara Cochrane, Robert Kridel, Ella R. Thompson, Piers A. Blombery, Hennes Tsang, Jay Gunawardana, Joshua W.D. Tobin, Victoria Shelton, Mario Luiz Marques-Piubelli, Chan Yoon Cheah, Daniela Dueñas, Stephen H. Kazakoff, Michael MacManus, John Francis Seymour, Colm Keane, Mohamed Shanavas, David Christie, Tara Baetz, Marianne Brodtkorb, Li Li, Peter C. O’Brien, Michael R. Green, Anna Johnston, Nathalie Johnson, Sidney Davis, Samantha Hershenfield, Andrew McCann
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
EBioMedicineVol. 110
Institutions
Oslo University Hospital (NO), Royal Adelaide Hospital (AU), Memorial Sloan Kettering Cancer Center (US), Ochsner Health System (US), The University of Texas MD Anderson Cancer Center (US), The University of Queensland (AU), Queen's University (CA), QIMR Berghofer Medical Research Institute (AU), Royal Brisbane and Women's Hospital (AU), Gold Coast Hospital (AU), Peter MacCallum Cancer Centre (AU), Auckland City Hospital (NZ), McGill University Health Centre (CA), Princess Alexandra Hospital (AU), The Alfred Hospital (AU), Sir Charles Gairdner Hospital (AU), Aarhus University Hospital (DK), Princess Margaret Cancer Centre (CA), Royal Hobart Hospital (AU), Mater Research (AU), Mater Adult Hospital (AU), Pathwest Laboratory Medicine (AU)
Funders
Mater Foundation, University of Texas MD Anderson Cancer Center, Medical Research Council, National Health and Medical Research Council, Cancer Council Victoria